1. P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHERAPY FOR TREATMENT-NAIVE PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. (23rd June 2022) Authors: Hasegawa, K.; Wei, A. H.; Garcia-Manero, G.; Daver, N. G.; Rajakumaraswamy, N.; Iqbal, S.; Chan, R. J.; Hu, H.; Tse, P.; Yan, J.; Zoratti, M. J.; Xie, F.; Sallman, D. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1922: EFFECTIVENESS OF AZACITIDINE IN FRONTLINE HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A RETROSPECTIVE COHORT STUDY OF 382 PATIENTS. (23rd June 2022) Authors: Rajakumaraswamy, N.; Gandhi, M.; Wei, A. H.; Sallman, D. A.; Daver, N. G.; Mo, S.; Iqbal, S.; Chen, M.; Wang, Y.; Vyas, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. (23rd June 2022) Authors: Paul, B.; Liedtke, M.; Siegel, D. S.; Khouri, J.; Hillenglass, J.; Rifkin, R.; Gandhi, M. D.; Kin, A.; Levy, M. Y.; Mohrbacher, A.; Schmidt, W.; Silbermann, R.; Cottini, F.; Sborov, D. W.; Walker, R.; Murphy, M.; Gu, L.; Chen, A.; Rajakumaraswamy, N.; Usmani, S. Z. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗